Sexual health support for bladder cancer patients
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study from the University of Aarhus looks at ways to support sexual health in people who have been treated for bladder cancer. If you are a Danish-speaking adult who had bladder cancer treatment about a year ago and have noticed changes in sexual function, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with bladder cancer and had your first treatment about 12 months ago.
- You had one of these treatments: TUR-B (a scope procedure to remove the tumor), TUR-B plus intravesical therapy (medicine placed directly into the bladder), or cystectomy (surgery to remove the bladder).
- You have noticed changes or problems with sexual function that you think are related to your cancer or its treatment.
- You can speak and understand Danish.
- You are 18 years old or older.
- You have not had breast cancer or any other cancer in the pelvic area (such as rectal, prostate, ovarian, uterine, cervical, or penile cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study explores how bladder cancer and bladder removal surgery affect your sex life and sexual recovery. By sharing your experience in a private interview, you can help doctors and nurses better support other women undergoing similar treatments.
This study asks women with bladder cancer to complete questionnaires about how they cope emotionally and about sexual health. It may help researchers understand what support survivors need and improve survivorship care.
This study looks at the information and support needs of people who have had bladder cancer and undergone a cystectomy. It aims to see how these needs change over time and to improve supportive care after surgery.
This study follows people with urothelial cancer and certain rare genital (genitourinary) cancers over time to learn how these diseases progress. It may help researchers understand patterns of symptoms and outcomes, even if it is not a drug trial.
This study tests a home-based program of support and education for people with early-stage bladder cancer who are receiving bladder perfusion therapy. The goal is to see if it improves your well-being and helps you manage treatment at home.
This study looks at tumor and blood samples from people with muscle-invasive bladder cancer to find markers that help predict how the disease will progress. It aims to improve personalized treatment for those with this specific stage of bladder cancer.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.